CN Patent
CN102711800A — 治疗糖尿病的组合物和方法
Assigned to Biokier Inc · Expires 2012-10-03 · 14y expired
What this patent protects
本发明涉及通过绕过上消化道递送丁酸、胆汁酸、长链脂肪酸或谷氨酰胺至结肠治疗某些相关疾病诸如糖尿病、肥胖症等的方法。该组合物通过相同或不同的给药途径与单胺再摄取抑制剂诸如安非他酮联合。
USPTO Abstract
本发明涉及通过绕过上消化道递送丁酸、胆汁酸、长链脂肪酸或谷氨酰胺至结肠治疗某些相关疾病诸如糖尿病、肥胖症等的方法。该组合物通过相同或不同的给药途径与单胺再摄取抑制剂诸如安非他酮联合。
Drugs covered by this patent
- Vascepa (ICOSAPENT ETHYL) · Amarin Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.